EPO non-lytic Recombinant Protein

• Background:

  Erythropoietin is the principal hormone involved in the regulation of erythropoiesis by stimulating the proliferation and differentiation of erythroid progenitor cells and the maintenance of a physiological level of circulating erythrocyte mass. It is a glycoprotein produced primarily by the kidney. The biological effects of EPO are mediated by the erythropoietin receptor (Epo R) . Genetic variations in EPO is associated with susceptibility to microvascular complications of diabetes type 2 (MVCD2) (including diabetic retinopathy, diabetic nephropathy leading to end-stage renal disease and diabetic neuropathy) . It is used for the treatment of anemia and misused as a performance-enhancing drug in endurance athletes.

• NCBI Gene ID:

  2056

• Swiss Prot:

  P40933

• Accession Number:

  NP_000790

• Tag:

  Fc Tag

• Type:

  Recombinant Proteins

• Source:

  CHO cells

• Field of Research:

  Cancer, Cell Cycle, Obesity, Signal Transduction

• Buffer:

  Lyophilized from 0.2um-filtered solution in PBS. Reconstitute at 100 μ g/ml in sterile PBS.

• Shipping Conditions:

  Room Temp

• Storage Conditions:

  Stable for at least 1 year after receipt when stored at -20˚ C. Working aliquots are stable for up to 3 months when stored at -20˚ C.

• Applications Notes:

  This recombinant proteins is for research use only.

• NCBI Official Name:

  Erythropoietin

• NCBI Organism:

  Homo sapiens

• Other Product Names:

  Erythropoietin, Epoetin

• Species:

  Human

• Protein ID:

  62240997

• Physical Properties:

  Lyophilized

• CAS Number:

  9000-83-3